PSDKU PKM-PE Team Presents Alternative Treatment for Mammary Gland Cancer

Share on facebook
Share on google
Share on twitter
Share on linkedin
PSDKU Banyuwangi PKM-PE TEAM, (from the left) Estiary Wilujeng, Mega Wulandari Harsono Putri, and Nadia Marva Triana. (Photo: By courtesy)

UNAIR NEWS – A PKM-PE (Research) Team Universitas Airlangga Off Main Campus Program (PSDKU) successfully presented an alternative treatment for mammary gland cancer through an in vivo study of Glycine max (L) extract. The research is one of the fields of proposals funded by the Ministry of Research, Technology, and Higher Education (Kemenristek Dikti).

The PKM-PE team consists of three members and students of PSDKU UNAIR Banyuwangi Veterinary Medicine (FKH). They are Nadia Marva Triana (FKH 2016), Estiary Wilujeng (FKH 2016), and Mega Wulandari Harsono Putri (FKH 2017).

Interviewed by UNAIR NEWS on June 22, Nadia Marva Triana as the team leader explained the importance of researching alternative treatments for mammary gland cancer. Mammary gland cancer is a disease caused by multicellular cell proliferation, which causes changes in uncontrolled cell properties in mammary organs (breasts).

“Because cancer usually attacks any parts of the body, we focus on the treatment of mammary gland cancer. This is because this cancer usually attacks pets and humans, “said Nadia.

This study used experimental animals, white mice (Rattus novergicus) Sprague Dawley strains because white mice are adaptable to new environments and are easy to use for research.

The research conducted over the past three months has passed the code of ethics test. The treatment then carried out, and at the end of the research, histopathology on the mammary organ of white mice was conducted.

During the research process, Nadia and the team experienced several constraints in the process, such as the material which is not available, so it must be ordered first.

In the end, Nadia hoped the results of their research could be used to treat mammary gland cancer in animals so that it becomes an alternative herbal cancer treatment for mammary glands.

“We hope that in the future, besides being beneficial to the community, the results of our research can be published in national or international scientific journals. Furthermore, we expect the patent right, ” she concluded.

Author: Dian Putri Apriliani

Editor: Nuri Hermawan

Berita Terkait



Media komunikasi dan informasi seputar kampus Universitas Airlangga (Unair).

Leave a Replay

Close Menu